Generics

PRINCETON, N.J. — Sandoz on Thursday announced the launch of its authorized generic of Shire’s Adderall XR (dextroamphetamine sulfate, dextroamphetamine saccharate, amphetamine sulfate and amphetamine aspartate) extended-release capsules. The drug is indicated to treat attention deficit/hyperactivity disorder in children. 

 

WESTON, Fla. — Apotex on Thursday announced that it would be re-entering the market with its authorized generic version of Paxil CR (paroxetine controlled-release) tablets. 

 

Apotex’s authorized generic will be available in 12.5-, 25- and 37.5-mg dosage strengths. The drug had about $126 million in sales for the 12 months ended June 2016, according to IMS Health. 

 

SILVER SPRING, Md. — The Food and Drug Administration has approved Perrigo’s generic of Suprep (sodium sulfate/potassium sulfate/magnesium sulfate) oral solution, the company announced Tuesday. The drug is indicated as a treatment for cleansing of the colon in preparation for colonoscopy in adults. 

 

The drug had U.S. sales of $178 million for the 12 months ended July 2016. 

 

CVS Health Research Institute study touts tailored adherence interventions

 

SILVER SPRING, Md. — The Food and Drug Administration has approved Aurobindo’s generic of Cordarone (amiodarone hydrochloride) tablets, the company announced Thursday. The drug is indicated to treat recurrent heart rhythm problems.

 

Aurobindo’s generic will be available in 200-mg dosage strength. The product had U.S. sales of about $24.1 million for the 12 months ending June 2016, according to IMS Health.

 

GREENVILLE, N.C. — Mayne Pharma on Thursday announced that it had acquired a portfolio of dermatology foam products from GSK in $50.1 million deal. Among the portfolio’s products are U.S. rights to acne treatment Fabior (tazarotene) foam and plaque psoriasis treatment Sorilux (calcipotriene) foam. The company also gains the Canadian rights to Luxiq and Olux-E, as well as Mexican rights to betamethasone foam. 

 

SILVER SPRING, Md. — The Food and Drug Administration has approved Amerigen Pharmaceuticals’s generic of Temodar (temozolomide) capsules, the company announced Thursday. The drug is indicated to treat certain types of brain cancer. 

 

Amerigen’s generic has launched and is available in 5-, 2-, 100-, 140-, 180- and 250-mg dosage strengths. 

 

LAKE FOREST, Ill. — Generics company Akorn on Thursday announced that it had added a Walgreens executive to its staff. Rob Monahan, most recently Walgreens’s VP mergers and acquisitions, has been named Akorn’s VP corporate development.